Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984290 · ClinicalTrials.gov registry record · NA
Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT05984290 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 90 participants.
The verdict
NCT05984290, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The objective of this orthokeratology study is to evaluate the safety and effectiveness of the Arise Orthokeratology Lens with non-spherical posterior peripheral curves
Interventions
- DEVICE orthokeratology lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2024-06-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05984290
The ClinicalTrials.gov registry entry for NCT05984290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which orthokeratology lens is the first listed.
NCT05984290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05984290 about?
NCT05984290 is a clinical study titled "Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens". The objective of this orthokeratology study is to evaluate the safety and effectiveness of the Arise Orthokeratology Lens with non-spherical posterior peripheral curves
What is the current status of trial NCT05984290?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2023-07-11. Estimated completion is 2024-06-27.
What interventions are being tested in trial NCT05984290?
The interventions under investigation include: orthokeratology lens (DEVICE).
Who is sponsoring clinical trial NCT05984290?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.